Ablate and pace strategy for atrial fibrillation: Long-term outcome of AIRCRAFT trial

Europace

Volumn 9, Issue 7, 2007, Pages 498-505

  Lim, Kang Teng ^a   Davis, Michael J E ^a,b   Powell, Anne ^a,b   Arnolda, Leonard ^a   Moulden, Kath ^a   Bulsara, Max ^c   Weerasooriya, Rukshen ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Atrial fibrillation; AV junction ablation; Pacing

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; METOPROLOL;

AGED; ANAMNESIS; ARTICLE; AUSTRALIA; BRADYCARDIA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DYSPNEA; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL; THORAX PAIN; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WESTERN AUSTRALIA;

EID: 34547880392     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum091     Document Type: Article

References (35)

1. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347(23):1825-33.
2. European Heart Rhythm Association and the Heart Rhythm Society, Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006 15; 48(4):854-906.
3. Weerasooriya R, Davis M, Powell A, Szili-Torok T, Shah C, Whatley D et al. The Australian intervention randomized control of rate in atrial fibrillation trial (AIRCRAFT). J Am Coll Cardiol 2003;41 10):1697-1702.
4. Hawthorne G, Richardson J, Osborne R. The assessment of quality of life (AQoL) instrument: A psychometric measure of health-related quality of life. Qual Life Res 1999;8(3):209-24.
5. Willund I, Gorkin L, Pawitan Y, Schron E, Schoenberger J, Jared LL et al. Methods for assessing quality of life in the cardiac arrhythmia suppression trial (CAST). Qual Life Res 1992; 1(3):187-201.
6. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: Development and final revision of a health status measure. Med Care 1981;19(8):787-805.
7. Farshi R, Kistner D, Sarma JS, Longmate JA, Singh BN. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: A crossover open-label study of five drug regimens. J Am Coll Cardiol 1999;33(2):304-10.
8. Beasley R, Smith DA, McHaffie DJ. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation, Br Med J (Clin Res Ed) 1985;290(6461):9-11.
9. Falk RH, Leavitt JI. Digoxin for atrial fibrillation: A drug whose time has gone? Ann Intern Med 1991;114(7):573-5.
10. Stafford RS, Robson DC, Misra B, Ruskin J, Singer DE. Rate control and sinus rhythm maintenance in atrial fibrillation: National trends in medication use, 1980-1996. Arch Intern Med 1998;158 19):2144-8.
11. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336(8):525-33.
12. Barold SS, Ovsyshcher IE. Pacemaker-induced mitral regurgitation. Pacing Clin Electrophysiol 2005;28(5):357-60.
13. Twidale N, Sutton K, Bartlett L, Dooley A, Winstanley S, Heddle W et al. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol 1993;16(6):1275-84.
14. Edner M, Caidahl K, Bergfeldt L, Darpo B, Edvardsson N, Rosenqvist M. - Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J 1995;74(3):261-7.
15. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M et al. W. The ablate and pace trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998;2(2):121-35.
16. Brignole M, Menozzi C, Gianfranchi L, Musso G, Mureddu R, Bottoni N et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: A randomized, controlled study. Circulation 1998;98(10):953-60.
17. Ueng KC, Tsai TP, Tsai CF, Wu DJ, Lin CS, Lee SH et al. Acute and long-term effects of atrioventricular junction ablation and VVIR pacemaker in symptomatic patients with chronic lone atrial fibrillation and normal ventricular response. J Cardiovasc Electrophysiol 2001;12(3):303-9.
18. Daoud EG, Weiss R, Bahu M, Knight BP, Bogun F, Goyal R et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996;78(12):1433-6.
19. Manolis AG, Katsivas AG, Lazaris EE, Vassilopoulos CV, Louvros NE. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias. J Interv Card Electrophysiol 1998;2(1):71-6.
20. Szili-Torok T, Kimman GP, Theuns D, Poldermans D, Roelandt JR, Jordaens LJ. Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation. Eur J Pacing Electrophysiol 2002;4(1):61-5.
21. Vernooy K, Dijkman B, Cheriex EC, Prinzen FW, Crijns HJ. Ventricular remodeling during long-term right ventricular pacing following His bundle ablation. Am J Cardiol 2006;97(8):1223-7.
22. Tops LF, Schalij MJ, Holman ER, van EL, van der Wall EE, Bax JJ. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 2006;48(8):1642-8.
23. Verlato R, Turrini P, Baccillieri MS, Lafisca N, Piovesana P, Contessotto F. - Biventricular pacing and atrioventricular junction ablation as treatment of low output syndrome due to refractory congestive heart failure and chronic atrial fibrillation. Ital Heart J 2000;1(12):844-7.
24. Blanc JJ, Etienne Y, Gilard M. Assessment of left ventricular pacing in patients with severe cardiac failure after atrioventricular node ablation and right ventricular pacing for permanent atrial fibrillation. Eur J Pacing Electrophysiol 1999; 1 (1):47-8.
25. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005; 16(11):1160-5.
26. Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002; 39(8):1258-63.
27. Valls-Bertault V, Fatemi M, Gilard M, Pennec PY, Etienne Y, Blanc JJ. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Eur J Pacing Electrophysiol 2004;6(5):438-43.
28. Twidale N, Manda V, Holliday R, Boler S, Sparks L, Crain J et al. Mitral regurgitation after atrioventricular node catheter ablation for atrial fibrillation and heart failure: Acute hemodynamic features. Am Heart J 1999;138(6 Pt 1): 1166-75.
29. Lieberman R, Grenz D, Mond HG, Gammage MD. Selective site pacing: defining and reaching the selected site. Pacing Clin Electrophysiol 2004;27(6 Pt 2):883-6.
30. O'Donnell D, Nadurata V, Hamer A, Kertes P, Mohammed W. Bifocal right ventricular cardiac resynchronization therapies in patients with unsuccessful percutaneous lateral left ventricular venous access. Pacing Clin Electrophysiol 2005;28(Suppl 1):S27-30.
31. Gasparini M, Mantica M, Brignole M, Coltorti F, Galimberti P, Gianfranchi L et al. Long-term follow-up after atrioventricular nodal ablation and pacing: Low incidence of sudden cardiac death. Pacing Clin Electrophysiol 2000;23(11 Pt 2):1925-9.
32. Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001;344(14):1043-51.
33. Peters RHJ, Wever EFD, Hauer RNW, Wittkampf FHM, Medina EOR. Bradycardia dependent QT prolongation and ventricular fibrillation following catheter ablation of the atrioventricular junction witb radio-frequency energy. Pacing and Clinical Electrophysiology 1994;17(1): 108-12.
34. Geelen PETE, Brugada JOSE, Andries ERIK, Brugada PEDR. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1997; 20(2): 343-8.
35. Ozcan C, Jahangir A, Friedman PA, Munger TM, Packer DL, Hodge DO et al. Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and Long-term survival in patients with atrial fibrillation and left ventricular dysfunction. Am J Cardiol 2003;92(1):33-7.